Tilray Brands (TLRY) Net Cash Flow (2017 - 2026)
Tilray Brands (TLRY) posted Net Cash Flow of $1.8 million for Q1 2026, up 110.02% on a QoQ basis from -$18.4 million in Q4 2025, and down 84.85% year-over-year from $12.2 million in Q1 2025.
Tilray Brands (TLRY) Net Cash Flow (2017 - 2026) Analysis & Trends
Tilray Brands' Net Cash Flow history runs 10 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- Quarterly Net Cash Flow fell 84.85% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $43.7 million (down 24.16% YoY) and the FY2025 annual result came in at -$7.8 million, down 135.09% from the prior year.
- Net Cash Flow was $1.8 million for Q1 2026 at Tilray Brands, up from -$18.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $136.4 million in Q2 2022 and bottomed at -$299.4 million in Q4 2022.
- A 5-year average of -$4.9 million and a median of $1.8 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 578.83% — and 2025, when it surged 571.31%.
- Tilray Brands' Net Cash Flow stood at -$299.4 million in 2022, then jumped by 88.55% to -$34.3 million in 2023, then soared by 61.36% to -$13.2 million in 2024, then plunged by 39.23% to -$18.4 million in 2025, then surged by 110.02% to $1.8 million in 2026.
- Business Quant data shows TLRY's Net Cash Flow at $1.8 million in Q1 2026, -$18.4 million in Q4 2025, and $43.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.85 Mn |
| Feb 28, 2026 | 1.85 Mn |
| Nov 30, 2025 | -18.44 Mn |
| Nov 30, 2025 | -18.44 Mn |
| Aug 31, 2025 | 42.97 Mn |
| Aug 31, 2025 | 42.97 Mn |
| May 31, 2025 | 17.36 Mn |
| May 31, 2025 | 17.36 Mn |
| Feb 28, 2025 | 12.19 Mn |
| Feb 28, 2025 | 12.19 Mn |
| Nov 30, 2024 | -13.25 Mn |
| Nov 30, 2024 | -13.25 Mn |
| Aug 31, 2024 | -24.11 Mn |
| Aug 31, 2024 | -24.11 Mn |
| May 31, 2024 | 82.83 Mn |
| May 31, 2024 | 82.83 Mn |
| Feb 29, 2024 | 1.82 Mn |
| Feb 29, 2024 | 1.82 Mn |
| Nov 30, 2023 | -34.28 Mn |
| Nov 30, 2023 | -34.28 Mn |